Phase 4
N=161
Utility of Trimethoprim-sulfamethoxazole Use in Skin Abscess Management
Skin Diseases, Infectious
Bottom Line
View on ClinicalTrials.gov: NCT00679302 ↗Enrolled (actual)
161
Serious AEs
0.0%
Results posted
Apr 2014
Primary outcome: Primary: Skin Abscess Resolution — 4; 3 participants
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- Trimethoprim-sulfamethoxazole (Drug); Placebo group (Drug)
- Age
- Pediatric, Adult · 0+ yrs
- Sex
- All
- Sponsor
- St. Louis University
- Primary completion
- Feb 2008
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Skin Abscess Resolution |
4; 3 | — |
| SECONDARY New Lesion Development and Spread of Skin Abscesses (on Subject) |
15; 13 | — |
Summary
The purpose of this study is to determine if antibiotics are required in the management of skin abscess following incision and drainage.
Eligibility Criteria
Inclusion Criteria
- non-toxic patients
- immunocompetent patients
- 3 months to 18 years old
- English-speaking patients
- skin abscesses
- not on antibiotics
Exclusion Criteria
- toxic patients
- immunocompromising co-morbidities
- less than 3 months old or older than 18 years of age
- non-english speaking
- on antibiotics
Data sourced from ClinicalTrials.gov (NCT00679302). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.